定义耐治疗的大脑癌症:基因查以确定基因驱动的免疫调节和治疗耐药性
Zachary David Myers1, Sandro Matosevic2,3
1Department of Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, IN, USA.
Cancer gene therapy
|October 27, 2025
概括
基因查揭示了多种质母细胞瘤 (GBM) 攻击性的关键驱动因素,影响DNA修复,细胞循环和免疫逃避. 这些发现为GBM提供了洞察力.
科学领域:
- 神经瘤学神经瘤学
- 癌症基因组学 癌症基因组学
- 免疫学 免疫学 免疫学
背景情况:
- 多形质母细胞瘤 (GBM) 是一种高度侵袭性的大脑瘤,预后不佳.
- 瘤的攻击性源于由于累积突变的遗传和表型变异性.
- 识别瘤驱动因素对于治疗策略至关重要.
研究的目的:
- 分析和总结使用基因查工具的研究,如在GBM中CRISPR和RNAi.
- 将已识别的遗传驱动因素与GBM的攻击性和治疗耐药性联系起来.
- 探索这些基因驱动器在瘤微环境中的免疫逃避中的作用.
主要方法:
- 在多形质母细胞瘤的遗传查研究的系统审查.
- 分析已识别的致癌驱动基因及其功能.
- 检查遗传驱动因素对瘤微环境和免疫细胞功能的影响.
主要成果:
- 基因查确定了调节DNA修复,细胞循环和新陈代谢的关键GBM因素.
- 已识别的基因有助于GBM的攻击性和免疫细胞逃避.
- 这些基因影响细胞表面受体和影响免疫细胞的可溶性因素,特别是自然杀手 (NK) 细胞.
结论:
- 通过查发现的遗传驱动因素在GBM攻击性中发挥着关键作用.
- 这些驱动因素赋予GBM与化疗和放射治疗相比的竞争优势.
- 了解这些遗传程序对于开发针对瘤与宿主相互作用的新型GBM疗法至关重要.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


